Re: Selection of stem cells by using antibodies that target different CD34 epitopes yields different patterns of T-cell differentiation

Stem Cells

Volumn 25, Issue 9, 2007, Pages 2385-2386

  Sutherland, D Robert ^a   Keeney, Michael ^b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Bone marrow transplantation; CD34 selection; Flow cytometry; Monoclonal antibodies

Indexed keywords

CD34 ANTIGEN; EPITOPE; SIALIDASE;

CELL COMPARTMENTALIZATION; CHEMICAL ANALYSIS; EPITOPE MAPPING; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LYMPHOCYTE DIFFERENTIATION; MOLECULAR CLONING; STAINING; STEM CELL;

ANTIBODIES; ANTIGENS, CD34; CELL DIFFERENTIATION; CELL SEPARATION; CLONE CELLS; EPITOPES; FLOW CYTOMETRY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; T-LYMPHOCYTES;

EID: 34748855549     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0245     Document Type: Letter

References (11)

1. Otto M, Chen X, Martin WJ et al. Selection of stem cells by using antibodies that target different CD34 epitopes yields different patterns of T-cell differentiation. STEM CELLS 2007;25:537-542.
2. Sutherland DR, Anderson L, Keeney M et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 1996;5:213-226.
3. Keeney M, Chin-Yee I, Weir K et al. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. Cytometry 1998;34:61-67.
4. Gratama JW, Keeney M, Sutherland DR. Flow cytometric enumeration and immunophenotyping of hematopoietic stem and progenitor cells. Semin Hematol 2001;38:139-147.
5. Sutherland DR, Keeney M, Gratama JW. Enumeration of CD34+ hematopoietic stem and progenitor cells. In: Robinson JR, Darzynkiewicz Z, Dean PN, Rabinovitch PS, Stewart CS, Tanke HJ, Wheeless LL, eds. Current Protocols in Cytometry. New York: John Wiley and Sons Inc., 2003:1-23.
6. Keeney M, Chin-Yee I, Gratama JW et al. Isotype controls in the analysis of lymphocytes and CD34+ stem/progenitor cells by flow cytometry-time to let go! Cytometry 1998;34:280-283.
7. Sutherland DR, Keating A. The CD34 antigen: Structure, biology and potential clinical applications. J Hematother 1992;1:115-129.
8. Lanza R, Healy L, Sutherland DR. Structural and functional features of the CD34 antigen: An update. J Biol Regul Homeost Agents 2001;15:1-1.
9. Sutherland DR, Marsh JCW, Davidson J et al. Differential sensitivity of CD34 epitopes to cleavage by Pasteurella haemolytica glycoprotease: Implications for purification of CD34-positive progenitor cells. Exp Hematol 1992;20:590-599.
10. Shpall EJ, Jones RB, Franklin W et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 1994;12:28-36.
11. Vescio R, Schiller G, Stewart AK et al. Multicenter phase III trial to evaluate CD34+ selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma. Blood 1999;93:1858-1868.